This Therapeutics Company Granted Fast Track Designation By FDA

Seres Therapeutics Fast Tracks SER-155: A Potential Game-Changer in The Medical Field.

This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

Seres Therapeutics, a leading microbiome therapeutics platform company, has recently been granted Fast Track designation by the US Food and Drug Administration (FDA) for its investigational drug SER-155. In addition to th…